Penumbra Inc at Canaccord Genuity Growth Conference Transcript
Great. Thank you. Welcome. With us today -- welcome to the Canaccord Genuity 40th Annual Global Growth Conference. I'm Bill Plovanic. I'm a senior medical device analyst here at Canaccord.
I'm just excited to have Penumbra management with me today. Penumbra is a medical device company. They're focused on the development of novel products to address challenging medical conditions with unmet needs. We believe Penumbra is positioned for continued growth with a portfolio of products that address unmet needs, drive a paradigm change and are in the early stage of market penetration.
With me today is Adam Elsesser. He's CEO and founder of Penumbra. Adam, thanks for joining me today.
Yes. Thanks, Bill, for having us. Appreciate it.
Questions & Answers
No -- so I'd like,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |